
Your doctor may be
referring you to our office for evaluation of your baby because of your
age, because of a family history of a prior problem, because an
ultrasound suggested a possible problem with your baby, or perhaps
because a multiple marker screening test, commonly called the “AFP
test,” was found to be abnormal. We strongly encourage
patients to visit with our genetic counselor to discuss the specific
risks to your pregnancy, as well as to review the prenatal testing
options outlined below:
First Trimester
Screening
First Trimester Screening is a powerful new
screening option which will assess the possibility of a chromosomal
abnormality in the baby. It is a combination of a sonographic
measurement of the baby’s nuchal fold (skin thickness at back of
neck) with a blood test from the mother. Performed
appropriately, this test can identify 80-90% of babies with a
chromosome abnormality. The American College of Ob-Gyn (ACOG) is now
recommending that all pregnant women be given the option of having
this screening test. It must be performed between 11-14 weeks
gestation. The physicians and sonographers at PCI have been
certified to perform this test.

Second
Trimester Ultrasound
A detailed obstetric ultrasound performed ideally
between 18-22 weeks gestation is a non-invasive means of evaluating a
fetus for possible structural or chromosomal abnormality. While
able to provide significant information about a fetus, this procedure
cannot definitively rule out a chromosome abnormality even when normal.
Chorionic
Villus Sampling (CVS)
This procedure must be performed between 10 – 12
completed weeks gestation. It involves insertion of a needle into
the placental tissue (under ultrasound guidance) and withdrawing a small
amount of this tissue which is then sent to a laboratory to determine
the chromosomal make-up of the fetus. This test is highly accurate in
ruling out an abnormality of chromosome number, like Down syndrome.
The disadvantage of this test is that it carries a small risk of
pregnancy loss.

Amniocentesis
A genetic amniocentesis can be performed any time
after 15 weeks gestation. This is a very accurate test to rule out
a chromosome abnormality, similar to CVS. This test is also
performed under ultrasound guidance, and involves placement of a needle
into the amniotic fluid surrounding the fetus, withdrawing a small
amount of this fluid, and then sending it to a genetic laboratory for
evaluation. The disadvantage of this test is that it also carries
a small risk of pregnancy loss.
